Novavax's Future

I think the sky's the limit for the company, but these things do take some time to materialize. We just released phase two data, positive phase two data results on three different vaccines. Our Novavax technology delivered 80% better immune response than the gold standard high dose flu vaccine. So I think we've got something, we're sitting on something really special.